TY - JOUR
T1 - Harnessing potent therapies with care
T2 - enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma
AU - Ghatalia, Pooja
AU - Plimack, Elizabeth R.
PY - 2023/12
Y1 - 2023/12
KW - Antibodies, Monoclonal/therapeutic use
KW - Carcinoma, Transitional Cell/drug therapy
KW - Humans
KW - Urinary Bladder Neoplasms/drug therapy
UR - https://www.scopus.com/pages/publications/85169826604
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:001058283500001&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1038/s41571-023-00814-6
DO - 10.1038/s41571-023-00814-6
M3 - Comment/debate
C2 - 37667009
SN - 1759-4774
VL - 20
SP - 818
EP - 819
JO - Nature Reviews Clinical Oncology
JF - Nature Reviews Clinical Oncology
IS - 12
ER -